Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Naloxone for Opioid-induced Constipation in MMT
NCT02137213Phase 2Completed
- Sponsor
- Center for Addiction and Mental Health
- Start
- Aug 2014
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in opioid-induced constipation (OIC), sponsored by Center for Addiction and Mental Health. Started Aug 2014; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced constipation (OIC)
Beyond the preview
Go deeper on NCT02137213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02137213.